You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 130 No. 12, December 1995 TABLE OF CONTENTS
  Archives
  •  Online Features
  Papers
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Both Prostaglandin E2 and Nitric Oxide Sequentially Mediate the Tumor Necrosis Factor {alpha}–Induced Inhibition of Surfactant Synthesis by Human Type II Pneumocytes

Elena Vara, PhD; Javier Arias-Díaz, MD, PhD; Cruz Garcia, PhD; Jorge Hernández, MD, PhD; Jose L. Balibrea, MD, PhD

Arch Surg. 1995;130(12):1279-1286.


Abstract

Background
Tumor necrosis factor {alpha} (TNF-{alpha})—induced inhibition of surfactant synthesis seems to participate in the pathogenesis of the adult respiratory distress syndrome.

Objectives
To examine the ability of human type II pneumocytes to produce nitric oxide (NO) in the presence of TNF-{alpha} and, in addition, to explore the role of this radical in the transduction of the cytokine signal. Design: Multiple organ donors were the source of lung tissue specimens. Type II pneumocytes were isolated by enzymatic digestion, adherence separation of macrophages, and gradient purification. After 24-hour preculture, cells were cultured for 24 hours in the presence or absence of TNF-{alpha} (100 ng/mL), sodium nitroprusside (100 µmol/L), N{omega}-nitro-L-arginine methyl ester (NAME) (1 mmol/L), methylene blue (10 µmol/L), 8-bromo-3',5'-cyclic guanosine monophosphate (8-Br-cGMP) (1 mmol/L), prostaglandin E2 (PGE2) (0.1 µmol/L), indomethacin (30 µmol/L), and combinations. The NO release to the medium and cGMP and PGE2 contents of the cells were measured.

Results
The incorporation of14C-labeled glucose (D-[U-14C] glucose) into phosphatidylcholine and phosphatidylglycerol was selectively inhibited either by 8-Br-cGMP or in the presence of TNF-{alpha}, PGE2, or nitroprusside, all of which caused an increase in the intracellular levels of cGMP. The inhibitory effect of TNF-{alpha} was partially reverted by indomethacin, NAME, N-monomethyl arginine, or methylene blue. The inhibitory effect of PGE2 was partially reverted by NAME, while that of nitroprusside was reverted by methylene blue, but not by indomethacin. Tumor necrosis factor {alpha} induced an increase in PGE2 (4.31±0.27 vs 1.65±0.17-pg/µg protein, n=10, P<.01) and cGMP (0.238±0.012 vs 0.109±0.014-pmol/µg protein, n=10, P<.01) cell content and in the NO release to the medium (3.10±0.14 vs 1.19±0.11-nmol/µg protein, n=10, P<.01). The basal NO release to the medium was also increased in the presence of PGE2. The NAME, which blocked NO generation and cGMP increase, did not affect PGE2 production in response to TNF-{alpha}. However, indomethacin, which blocked PGE2 production, also blunted NO generation and cGMP increase.

Conclusions
The NO generation, secondary to PGE2 production, seems responsible for the TNF-{alpha}–induced inhibition of phosphatidylcholine synthesis by human type II pneumocytes. Nitric oxide seems to exert this effect through activation of guanylyl cyclase.

(Arch Surg. 1995;130:1279-1286)



Author Affiliations

From the Departments of Biochemistry (Facultad de Medicina) (Drs Vara and García) and Surgery (Hospital San Carlos) (Drs Arias-Díaz, Hernández, and Balibrea), Universidad Complutense, Madrid, Spain.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Inhibition of nitric oxide synthase attenuates NNMU-induced alveolar injury in vivo
Cruz et al.
Am. J. Physiol. Lung Cell. Mol. Physiol. 1997;273:L1167-L1173.
ABSTRACT | FULL TEXT  

Carbon Monoxide Contributes to the Cytokine-Induced Inhibition of Surfactant Synthesis by Human Type II Pneumocytes
Arias-Diaz et al.
Arch Surg 1997;132:1352-1361.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.